Cardiovascular science in france focus on familial cardiomyopathies and thrombophilia.
"Ce qui a peut-être transformé le plus profondément l'étude desêtres vivants, c'est l'accsà l'analyse d'objets nouveaux," or in other words, "That which had the greatest impact on the study of living subjects is access to the analysis of new objects" (François Jacob, 1965 Nobel Prize of Medicine). In the 20th century, it is recombinant-DNA technology that has opened a new chapter in the history of medicine, genetic medicine, because it has rendered the human genome accessible to analysis. The cardiovascular field has been rather slow to integrate the concepts and the tools of molecular biology and molecular genetics; however, this barrier has now been overcome, and it is an exciting time for the field. This article focuses on studies that are conducted in France in the context of national multidisciplinary INSERM networks and that deal with two types of hereditary forms of cardiovascular diseases, cardiomyopathies, and hereditary thrombophilia. © 1996, Elsevier Science Inc. (Trends Cardiovasc Med 1996;6:207-210).